A research-based treatment that combines psychotherapy with MDMA to help individuals with post-traumatic stress disorder (PTSD) process trauma and reduce symptoms when traditional approaches have not been effective.
If you’re living with post-traumatic stress disorder (PTSD) and have tried talk therapy, medications, or both without lasting relief, MDMA-assisted psychotherapy may offer a new path forward. This innovative treatment combines structured psychotherapy with the use of MDMA—administered in a safe, clinical environment—to help you process trauma more effectively and begin to heal.
MDMA (3,4-methylenedioxy-methamphetamine) is a synthetic compound that can temporarily reduce fear and defensiveness, enhance emotional insight, and increase trust and openness in the therapeutic relationship. When combined with psychotherapy, these effects create a unique opportunity to work through painful memories that may have felt too overwhelming in the past.
This treatment approach is currently in advanced clinical trials and is part of an Expanded Access program approved by the U.S. Food and Drug Administration (FDA), allowing select patients to receive the therapy before full approval is granted.
MDMA-assisted psychotherapy is not the same as recreational MDMA or Ecstasy. In clinical settings, MDMA is carefully dosed and administered under medical supervision, with the support of trained therapists before, during, and after the session. The goal is not to escape reality, but to face it with less fear and more clarity.
In earlier Phase 2 trials, 107 people with chronic, treatment-resistant PTSD received a structured course of MDMA-assisted psychotherapy. Results showed that:
These findings led the FDA to grant MDMA Breakthrough Therapy status in 2017, accelerating its path to potential approval.
The Behavioural Wellness Clinic participated in these trials at the University of Connecticut Health Center (UCHC), under the leadership of Dr. Monnica Williams and Sara Reed, MS. Our clinic now continues to offer this treatment through the Expanded Access program in partnership with the Multidisciplinary Association for Psychedelic Studies (MAPS).
The treatment process includes several stages:
Most participants in the Expanded Access program receive three MDMA sessions, each spaced about a month apart, with non-drug therapy sessions before and after to support the experience.
You may be a candidate for this treatment if:
Expanded Access allows individuals who meet certain criteria to receive this treatment before MDMA is formally approved for widespread use. Our clinical team will work with you to assess your eligibility and ensure your safety throughout the process.
If you’re living with PTSD and haven’t found relief through traditional therapies, you may be eligible for this promising treatment. Contact us to learn more about MDMA-assisted psychotherapy and to see if the Expanded Access program may be right for you.
Healing from trauma is possible. We’re here to help you find your way forward.